IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan
IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting
Seeking Alpha / 27 minutes ago 7 Views
Seeking Alpha / 27 minutes ago 7 Views
IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan
Comments